External ventricular drain market seen reaching $6.74 billion by 2030

The external ventricular drain market is forecast to grow from $4.99 billion in 2025 to $6.74 billion by 2030, driven by rising traumatic brain injuries, neurological disorders and broader neurocritical care use. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - External ventricular drains are used to relieve elevated intracranial pressure and help prevent further brain damage in patients with neurological injuries and disorders. - Rising demand for neurocritical care and brain-injury treatment is expanding the market for a device used to drain cerebrospinal fluid and monitor pressure in the brain.

What happened: - The Business Research Company said the external ventricular drain market was valued at $4.99 billion in 2025 and is projected to reach $5.33 billion in 2026. - The firm projects the market will grow to $6.74 billion by 2030, representing a 6.1% CAGR over the forecast period. - The release was issued Aug. 6, 2026, from London. - Download a free sample of the report. - View the full market report.

The details: - Earlier market growth was linked to traumatic brain injuries, intracranial hemorrhage cases, hydrocephalus, the expansion of neurosurgical care centers and wider use of critical care monitoring. - The market’s forecast growth is supported by rising neurological disorders, higher demand for advanced neurocritical care, new investment in neurosurgical infrastructure, growing awareness of intracranial pressure management and broader access to specialized neurological hospitals. - Expected trends include wider use of external ventricular drains in neurocritical care, more adjustable and continuous systems, tighter intracranial pressure management, better infection control in cerebrospinal fluid drainage and increased use in traumatic brain injury treatment. - An external ventricular drain removes excess cerebrospinal fluid from the brain’s ventricles into an external collection system. - The device is used to lower intracranial pressure, reduce headaches, nausea and altered consciousness, and help stabilize patients with cerebrospinal fluid buildup. - Traumatic brain injury remains a key demand driver because swelling, hemorrhage or fluid buildup can raise intracranial pressure and cause further damage. - The World Federation of Neurology said in October 2023 that more than 40% of the global population has a neurological condition, and that figure is expected to nearly double by 2050. - In 2025, North America held the largest share of the market. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The market forecast points to sustained demand from both acute care settings and the broader rise in neurological disease burden. - Product trends suggest customers want more control over pressure management and infection risk, which could favor newer EVD systems over basic drainage setups. - Regional growth appears tied to healthcare infrastructure and specialist access, with North America leading today and Asia-Pacific gaining momentum.

What's next: - The company expects the market to keep expanding through 2030 as hospitals invest more in neurocritical care and neurosurgical capacity. - The release says 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspots infographics and updated trend analysis. - The Business Research Company listed Saumya Sahay as a contact for expert inquiries.

The bottom line: - External ventricular drains are moving from a niche neuro device market into a steady growth category, supported by rising brain-injury cases and a growing global neurological disease burden.